지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.95 No.5
- 발행연도
- 2018.11
- 수록면
- 286 - 296 (11page)
이용수
초록· 키워드
오류제보하기
Purpose: Sentinel lymph node (SLN) biopsy (SLNB) is widely accepted for staging of melanoma patients. It has been shown that clinico-pathological features such as Breslow thickness, ulceration, age, and sex are better predictors of relapse and survival than SLN status alone. The aims of this study were to evaluate the long-term (10-year) prognostic impact of SLNB and to determine predictive factors associated with SLN metastasis, relapse, and melanoma specific mortality (MSM).
Methods: This was a prospective observational study on 289 consecutive patients with primary cutaneous melanoma who underwent SLNB from January 2000 to December 2007, and followed until January 2014, at an Italian academic hospital.
Results: SLN was positive in 64 patients (22.1%). The median follow-up was 116 months (79–147 months). Tenyear disease-free survival and melanoma specific survival were poor in patients with positive SLN (58.7% and 66.4%, respectively). Only the increasing Breslow thickness resulted independently associated to an increased risk of SLN metastasis. Cox regression analysis showed that a Breslow thickness >2 mm was an independent predictor of relapse, and male sex and Breslow thickness >2 mm was a predictor of MSM. At 10 years, SLN metastasis was not significantly associated to either relapse or MSM.
Conclusion: After the fifth year of follow-up, SLN metastasis is not an independent predictive factor of relapse or mortality which are mainly influenced by the characteristics of the primary tumor and of the patient. Patients with a Breslow thickness >2 mm regardless of the SLN status should be considered at high risk for 10-year relapse and mortality.
Methods: This was a prospective observational study on 289 consecutive patients with primary cutaneous melanoma who underwent SLNB from January 2000 to December 2007, and followed until January 2014, at an Italian academic hospital.
Results: SLN was positive in 64 patients (22.1%). The median follow-up was 116 months (79–147 months). Tenyear disease-free survival and melanoma specific survival were poor in patients with positive SLN (58.7% and 66.4%, respectively). Only the increasing Breslow thickness resulted independently associated to an increased risk of SLN metastasis. Cox regression analysis showed that a Breslow thickness >2 mm was an independent predictor of relapse, and male sex and Breslow thickness >2 mm was a predictor of MSM. At 10 years, SLN metastasis was not significantly associated to either relapse or MSM.
Conclusion: After the fifth year of follow-up, SLN metastasis is not an independent predictive factor of relapse or mortality which are mainly influenced by the characteristics of the primary tumor and of the patient. Patients with a Breslow thickness >2 mm regardless of the SLN status should be considered at high risk for 10-year relapse and mortality.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
수술 전 관상피내암으로 진단된 환자에서의 감시림프절 생검을 고려해야 하는 위험인자들에 대한 고찰
Journal of Breast Disease
2015 .12
-
Avoiding Unnecessary Sentinel lymph node Frozen Biopsy in Early Breast Cancer
대한외과학회 학술대회 초록집
2021 .05
-
The Expression of Carbonic Anhydrase (CA) IX/XII and Lymph Node Metastasis in Early Breast Cancer
Cancer Research and Treatment
2016 .01
-
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis
Journal of Gynecologic Oncology
2022 .09
-
Avoiding unnecessary intraoperative sentinel lymph node frozen section biopsy of patients with early breast cancer
Annals of Surgical Treatment and Research
2022 .05
-
Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues
Obstetrics & Gynecology Science
2022 .09
-
Sentinel Lymph Node Biopsy for Melanoma : What Have We Learned in 25 Years
대한임상종양학회 학술대회지
2016 .02
-
Accuracy of Sentinel Node in Detecting Lymph Node Metastasis in Primary Endometrial Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
PTEN Promoter Hypermethylation Is Associated with Breslow Thickness in Acral Melanoma on the Heel, Forefoot, and Hallux
Annals of Dermatology
2021 .01
-
Targeting of BUB1b Gene Expression in Sentinel Lymph Node Biopsies of Invasive Breast Cancer in Iranian Female Patients
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
The Lymphatic Drainage Pattern of Internal Mammary Sentinel Lymph Node Identified by Small Particle Radiotracer (99mTc-Dextran 40) in Breast
Cancer Research and Treatment
2019 .01
-
Anatomy Versus Physiology: Is Breast Lymphatic Drainage to the Internal Thoracic (Internal Mammary) Lymphatic System Clinically Relevant?
Journal of Breast Cancer
2023 .06
-
Utility of sentinel lymph node biopsy in papillary thyroid microcarcinoma
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2021 .12
-
Prognostic Significance of Epidermal Growth Factor Receptor Expression in Distant Metastatic Melanoma from Primary Cutaneous Melanoma
Annals of Dermatology
2021 .10
-
피부흑색종
대한의사협회지
2018 .01
-
An Elevated Platelet Count Increases the Risk of Relapse in Ulcerative Colitis Patients with Mucosal Healing
Gut and Liver
2018 .01
-
Feasibility of sentinel lymph node dissection using Tc-99m phytate in papillary thyroid carcinoma
Annals of Surgical Treatment and Research
2017 .11
-
Optimized Criteria for Sentinel Lymph Node Biopsy in Patients with Clinically Node Negative Breast Cancer
Journal of Breast Disease
2021 .01
-
Surgery of Lymph Nodes in Cutaneous Melanoma
대한임상종양학회 학술대회지
2018 .02
-
Evaluation of <sup>18</sup>F-FDG PET/CT Parameters for Detection of Lymph Node Metastasis in Cutaneous Melanoma
Nuclear medicine and molecular imaging : NMMI
2018 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2019-514-000098284